Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -0.16M
March 31, 2026 -164.38M
December 31, 2025 0.00
September 30, 2025 -0.226M
June 30, 2025 -0.145M
March 31, 2025 -9.986M
December 31, 2024 -0.357M
September 30, 2024 -0.644M
June 30, 2024 -122.09M
March 31, 2024 -166.34M
September 30, 2023 -0.022M
June 30, 2023 -0.532M
March 31, 2023 0.065M
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 -0.056M
September 30, 2021 0.00
June 30, 2021 -0.243M
March 31, 2021 -55.98M
December 31, 2020 -8.474M
September 30, 2020 0.00
June 30, 2020 -0.874M
March 31, 2020 -0.131M
December 31, 2019 0.00
September 30, 2019 0.00
Date Value
June 30, 2019 -0.013M
March 31, 2019 0.009M
December 31, 2018 0.113M
September 30, 2018 -7.494M
June 30, 2018 -0.482M
March 31, 2018 0.00
December 31, 2017 -0.05M
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 -0.002M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 -0.0032M
December 31, 2015 0.00
September 30, 2015 -0.0467M
June 30, 2015 -0.0794M
March 31, 2015 -0.0004M
December 31, 2014 0.00
September 30, 2014 -0.2157M
June 30, 2014 -0.3858M
March 31, 2014 -19.80M
December 31, 2013 0.0016M
September 30, 2013 -3.281M
June 30, 2013 -0.0018M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 0.643M
MiMedx Group, Inc. 12.60M
ABVC BioPharma, Inc. 0.00
Enovis Corp. -0.38M
Edwards Lifesciences Corp. -0.50M